Fresenius Medical Care (FMS) Tops Q2 EPS by 33c

Fresenius Medical Care (NYSE: FMS) reported Q2 EPS of EUR0.70, EUR0.33 better than the analyst estimate of EUR0.37. Revenue for the quarter came in at EUR4.77 billion versus the consensus estimate of EUR5.44 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• Accenture (ACN) spreader of 22700 contracts of August 120 puts and 22200 contracts of August 130 calls as share price down 7.2%